Written and maintained by CASRAI Editorial Board
Last updated
This page describes products and general use; it is not medical advice.
Short answer
Tielle is a brand of multi-layered hydropolymer foam wound dressings featuring proprietary LiquaLock technology. Engineered for exuding partial- and full-thickness wounds, Tielle expands to conform to the wound bed, locks exudate within its core to prevent periwound maceration, and maintains moisture vapor balance under compression bandaging across clinical, home-health, and acute-care settings.
Definition and scope
Tielle hydropolymer dressings represent a class of advanced medical dressings originally developed by Johnson & Johnson Medical and subsequently produced under Systagenix, KCI, and 3M. Unlike passive gauze pads, hydropolymer dressings actively manage exudate to maintain an optimal moist physiological wound-healing environment.
The U.S. Food and Drug Administration (FDA) cleared the primary Tielle dressing line under several premarket 510(k) notifications:
- K964016: Original TIELLE Hydropolymer Foam Dressing (Johnson & Johnson Medical, cleared December 31, 1996).
- K983394: Modification to the base hydropolymer matrix (cleared November 3, 1998).
- K983234: TIELLE Plus Hydropolymer Adhesive Dressing with increased fluid handling capacity (cleared November 25, 1998).
The FDA classifies these dressings under Product Code MGP (Dressing, Wound And Burn, Occlusive), an unclassified pre-amendments device category reviewed by General Hospital and Plastic Surgery panels, with related liquid/foam bandage standards under 21 CFR 880.5090.
Clinical indications include Stage II to IV pressure ulcers, lower-extremity ulcers (venous, arterial, and mixed), diabetic foot ulcers, donor sites, and surgical incisions. Tielle is strictly contraindicated for full-thickness third-degree burns, lesions with active vasculitis requiring continuous vessel monitoring, and known hypersensitivity to polyurethane foams or acrylic adhesives.
How it works or how it is used in practice
Tielle functions through a three-layer architecture powered by LiquaLock technology:
- Wound Bed Conformance: The contact layer is an open-cell hydropolymer island. Upon absorbing fluid, it swells downward and outward, conforming to irregular wound contours and eliminating dead space where fluid pools.
- Horizontal Fluid Lock: Fluid is transferred to an internal wicking matrix that distributes exudate horizontally. LiquaLock locks exudate inside the polymer matrix, preventing lateral leakage onto intact periwound skin and preventing maceration.
- Moisture Vapor Transmission: The outer polyurethane backing is a waterproof, bacteria-resistant barrier that allows continuous moisture vapor transmission (MVTR) to facilitate evaporation.
Unlike open-cell foams or conventional highly absorbent wound dressings, Tielle retains fluid under external pressure. Under multi-layer compression bandaging (up to 40 mmHg), LiquaLock retains fluid within its matrix rather than squeezing it back into the wound bed.
A multicenter primary care trial by Diehm and Lawall (2005, PMCID: PMC7951714) evaluated 6,993 patients treated with Tielle for venous leg ulcers (59.8%), pressure ulcers (26.6%), and diabetic foot disease (9.5%). Key clinical findings showed:
- Wound Area Reduction: Mean wound area decreased by 78.2% at 4 weeks and 85.1% at 12 weeks.
- Healing Rates: Complete closure reached 43.3% at 4 weeks and 59.1% at 12 weeks.
- Exudate Control: Wounds with medium or strong exudate dropped from 57.4% at baseline to 6.7% at 4 weeks and 4.0% at 12 weeks.
- Nursing Efficiency: Dressing change frequency fell from 5 to 3 per week (a 43% reduction).
- Safety: 97.1% of patients remained free of adverse events.
Types or related concepts
The Tielle family comprises five distinct configurations tailored to exudate levels and wound anatomy:
| Variant | Exudate & Core Structure | Border & Format | Clinical Use | HCPCS Code |
|---|---|---|---|---|
| TIELLE Hydropolymer Adhesive | Low to moderate exudate; standard hydropolymer pad | Integrated acrylic adhesive border | Shallow pressure ulcers, venous ulcers, abrasions | A6210 (≤16 sq. in.) / A6212 (>16 to ≤48 sq. in.) |
| TIELLE Plus | Moderate to heavy exudate; pad plus superabsorbent core | Integrated perimeter adhesive border | Heavily draining chronic ulcers, surgical incisions | A6210 (≤16 sq. in.) / A6212 (>16 to ≤48 sq. in.) |
| TIELLE Lite | Non-to-low exudate; thin profile | Thin adhesive border, polyurethane film | Superficial cuts, skin tears, donor sites | A6210 (≤16 sq. in.) |
| TIELLE Non-Adhesive | Low to heavy exudate; multi-layer pad | Non-adhesive; requires secondary wrap | Fragile skin, beneath compression wraps | A6209 (≤16 sq. in.) / A6211 (>16 to ≤48 sq. in.) |
| TIELLE Packing | Moderate to heavy exudate; narrow strip | Non-adhesive strip | Deep cavities, sinus tracts, tunneling | A6214 (Filler, per gram) |
In clinical practice, hydropolymers occupy a distinct therapeutic niche. Unlike hydrocolloid dressings for pressure ulcers, which dissolve into a gel, hydropolymers remain intact. Compared to silicone foam wound dressings, which emphasize atraumatic removal, hydropolymers focus on expanding to seal dead space. They also differ from cleanser-impregnated polymeric foam dressings.
Where it matters for labs, clinics or supply decisions
Managing hydropolymer dressings involves specific clinical, regulatory, and supply requirements:
Clinical Research Protocols
In dermatological and surgical clinical trials, dressings with up to 7-day wear times minimize dressing disturbance, stabilize tissue beds, and reduce scheduled nursing visits that could otherwise introduce protocol variability.
Medicare Part B & DME MAC Reimbursement
Under CMS DME MAC Surgical Dressings Policy (LCD L33831 and Policy Article A54563), Medicare Part B covers hydropolymer dressings when specific conditions are met:
- Qualifying Wound: Medically necessary for wounds caused by surgical procedures or debrided by a licensed clinician (sharp, enzymatic, or autolytic). Intact surgical incisions generally do not qualify.
- Documentation: Medical records must document weekly evaluations, dimensions (length, width, depth), drainage volume, and expected change frequency.
- HCPCS Coding: Billing is determined by pad area and border: A6209/A6211 for non-bordered pads and A6210/A6212 for bordered pads, matching the pad area rather than total adhesive margins.
Procurement and Storage
Clinics typically standardize on three core dimensions (2.75 × 3.5 in., 4.25 × 4.25 in., and 7 × 8 in. sacral) to minimize inventory bloat. Dressings must be stored in dry conditions (59°F to 86°F / 15°C to 30°C) to maintain adhesive shelf life.
Common misunderstandings
- Treating Tielle as an Amorphous Gel: Tielle is a cross-linked polyurethane foam, not an amorphous hydrogel or dissolving hydrocolloid. It does not dissolve or leave gel residue in the wound bed upon removal.
- Assuming Standalone Antimicrobial Efficacy: Standard Tielle contains no active antimicrobials (such as ionic silver). Infected wounds require concurrent systemic medical treatment.
- Selecting Size by Total Border: The central absorbent pad, not the outer adhesive border, must overlap wound margins by at least 1 cm (0.4 in.) to ensure proper conformance.
- Billing Bordered Codes for Non-Adhesive Formats: Billing non-adhesive pads under bordered HCPCS codes (A6210 instead of A6209) is a frequent DME MAC audit error.
Frequently asked questions
How long can a Tielle dressing remain in place?
Tielle dressings can remain in place for up to 7 days, depending on exudate volume. Dressings must be changed when drainage reaches the edges of the central absorbent island or per clinical assessment.
Is Tielle dressing waterproof?
Yes. The polyurethane top film is waterproof and impermeable to bacteria. Patients may shower with the dressing in place if the adhesive seal remains intact. The dressing must not be submerged in water.
Can Tielle be applied underneath compression wraps?
Yes. Tielle and Tielle Plus are cleared for use under multi-layer compression bandaging. LiquaLock technology locks fluid within the foam matrix under pressure, preventing exudate from being forced back into the wound bed.
What is the difference between Tielle and Tielle Plus?
Standard TIELLE features a single hydropolymer foam layer for low to moderate exudate. TIELLE Plus contains an integrated superabsorbent wicking core designed to handle moderate to heavy wound exudate.
Sources
- U.S. Food and Drug Administration. Premarket Notification 510(k) K964016: TIELLE Hydropolymer Foam Dressing. Johnson & Johnson Medical, Inc. Cleared December 31, 1996. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K964016 (Read November 9, 2026).
- U.S. Food and Drug Administration. Premarket Notification 510(k) K983234: TIELLE Plus Hydropolymer Adhesive Dressing. Johnson & Johnson Medical / Ethicon, Inc. Cleared November 25, 1998. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K983234 (Read November 9, 2026).
- U.S. Food and Drug Administration. Device Classification Database: Product Code MGP (Dressing, Wound And Burn, Occlusive). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?PCD=MGP (Read November 9, 2026).
- Centers for Medicare & Medicaid Services. Local Coverage Determination (LCD) L33831 & Policy Article A54563: Surgical Dressings. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54563 (Read November 9, 2026).
- Diehm C, Lawall H. Evaluation of Tielle hydropolymer dressings in the management of chronic exuding wounds in primary care. International Wound Journal. 2005;2(1):26-35. PMCID: PMC7951714. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951714/ (Read November 9, 2026).
- Schulze HJ. Clinical evaluation of TIELLE* Plus dressing in the management of exuding chronic wounds. British Journal of Community Nursing. 2003;8(11 Suppl):18-22. PMID: 15115220. https://pubmed.ncbi.nlm.nih.gov/15115220/ (Read November 9, 2026).
